Interview: Dr. Amr Morsy – CEO, Rameda, Egypt
Five days before the January 25th revolution of 2011, Rameda changed ownership and CEO Amr Morsy set out to turn-around the mismanaged business. Five years later, revenues are up 4.5…
Rameda aims to become the most valuable emerging pharmaceutical company in Egypt. The company’s mission is to provide customers with quality health care solutions in a cost effective manner by developing products and services that satisfy their health requirements.
Rameda began operations in 1994 and was established by a group of Gulf investors with the intention of creating one of the largest pharmaceutical operations in the region.
Owners hired V-Konsult of Germany to create a state-of-the art design, and British Carter Construction company was contracted to build the Rameda’s facilities.
In 1999, Rameda entered into an agreement with Alcon to manufacture – under license – their ophthalmology products. In order to guarantee the quality of their products, Alcon built one of the highest quality eye production facilities in the region at Rameda.
In 2011, Compass Capital led a consortium of private equity investors for the acquisition of 100% of Rameda. Compass Capital plans to establish Rameda as a regional leader in the industry.
To execute this strategy Rameda hired a new management team with a proven track record to complement the existing team.
Contact
Cairo Scientific Office
8 Geziret El Arab Street (23rd Floor), Mohandessin, Giza, Egypt
+(202) 376 130 46 / 58 / 74
+(202) 376 130 18
Factory
Second Industrial Zone, plot number 5
Sixth of October, Egypt
+( 202) 383 31887 – 383 31848
+(202) 383 31849
Five days before the January 25th revolution of 2011, Rameda changed ownership and CEO Amr Morsy set out to turn-around the mismanaged business. Five years later, revenues are up 4.5…
BD’s Loay Badr outlines the rationale behind the medtech giant’s recent establishment of a direct presence in Egypt, the significant opportunities for medical device players in the country as it…
Country President, Hatem Werdany, provides an overview of AstraZeneca’s 50+ year legacy in Egypt and outlines the company’s plans to launch up to 25 new products there over the next…
Boehringer Ingelheim’s Marianne Abou Elkheir, General Manager and Head of Human Pharma for Levant, Iraq and North-East Africa (LINEA) and Sub-Saharan Africa (SSA), walks us through her career trajectory and…
As Egypt moves towards universal healthcare coverage for its 100 million-plus population, the country has become the fastest growing pharma market in the Middle East and Africa region with a…
Dr Amel El Beshlawy, founder of Egyptian Thalassemia Association (ETA) and Professor of Pediatric Hematology at the Pediatric Hospital of Cairo University, is considered the Middle East’s leading authority on…
PhRMA’s Middle East & Africa (MEA) group appoints a ‘champion’ for each of its markets to bring the priorities of that country to the agenda of the MEA executive committee.…
Sherif Amin, an 18-year industry veteran with 12 years of experience in oncology leadership roles across MEA, is the recipient of several awards, including the 2019 Oncology President Award, 2015…
Back in June 2022, Pfizer signed a memorandum of understanding (MoU) with the Egyptian Ministry of Health (MoH) to transfer the technology for producing its pneumococcal vaccine. The fifth highest…
Internationally renowned healthcare quality and safety expert Dr Ashraf Ismail explains the concept behind the Egyptian General Authority for Healthcare Accreditation and Regulation (GAHAR), its work in setting and implementing…
Under the auspices of a wide-ranging Vision 2030 economic transformation plan, Egypt is moving towards covering the entirety of its 100 million plus population under a universal healthcare insurance scheme.…
Pfizer’s general manager for Egypt, Ahmed El-Shazly, comments on his return to Egypt after 19 years away, the significant opportunities ahead for the affiliate as it looks to find its…
Mohamed Ali Abd El Azim gives several insights into GSK’s sizeable production footprint in Egypt, how the organisation’s aims dovetail with Egypt’s healthcare transformation, and what makes him proud to…
See our Cookie Privacy Policy Here
